Multifunctional nanoagent for enhanced cancer radioimmunotherapy via pyroptosis and cGAS-STING activation

Abstract The immunosuppressive tumor microenvironment (ITME) and inherent radioresistance of tumor cells limit the effectiveness of radioimmunotherapy and exacerbate immune evasion. To address these challenges, PEGylated Azacitidine-loaded and Mn2+-doped calcium carbonate nanoparticles (A@MCP NPs) a...

Full description

Saved in:
Bibliographic Details
Main Authors: Ziting Xu, Yang Gao, Li Zhang, Yingshan Gao, Yushu Liao, Yu Liang, Zhen Yuan, Yingjia Li, Bingxia Zhao, Ge Wen
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-025-03608-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849761586564038656
author Ziting Xu
Yang Gao
Li Zhang
Yingshan Gao
Yushu Liao
Yu Liang
Zhen Yuan
Yingjia Li
Bingxia Zhao
Ge Wen
author_facet Ziting Xu
Yang Gao
Li Zhang
Yingshan Gao
Yushu Liao
Yu Liang
Zhen Yuan
Yingjia Li
Bingxia Zhao
Ge Wen
author_sort Ziting Xu
collection DOAJ
description Abstract The immunosuppressive tumor microenvironment (ITME) and inherent radioresistance of tumor cells limit the effectiveness of radioimmunotherapy and exacerbate immune evasion. To address these challenges, PEGylated Azacitidine-loaded and Mn2+-doped calcium carbonate nanoparticles (A@MCP NPs) are synthesized as multifunctional nanoagent to enhance radioimmunotherapy outcomes. Upon acidic TME, the release of Ca2+ and Mn2+ from A@MCP NPs co-triggers intracellular reactive oxygen species (ROS) generation via Ca2+ overload and Fenton-like reactions, inducing cytochrome C release and caspase-3 activation. Concurrently, released Azacitidine inhibits DNA methylation, upregulating GSDME expression in irradiated tumor cells, which synergistically amplifies caspase-3/GSDME-induced pyroptosis. The resulting pyroptotic cell damage, coupled with radiotherapy (RT)-induced DNA, activates Mn2+-sensitized cGAS-STING pathways, amplifying immune responses. Collectively, A@MCP, as a nano radiosensitizer, together with RT, co-activates pyroptosis and cGAS-STING to further amplify anti-tumor immune response, overcome ITME-mediated resistance and offer significant potential for improved cancer radioimmunotherapy.
format Article
id doaj-art-028ae9e5bd424af8b50cf68bec09c1ad
institution DOAJ
issn 1477-3155
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj-art-028ae9e5bd424af8b50cf68bec09c1ad2025-08-20T03:05:59ZengBMCJournal of Nanobiotechnology1477-31552025-07-0123111610.1186/s12951-025-03608-3Multifunctional nanoagent for enhanced cancer radioimmunotherapy via pyroptosis and cGAS-STING activationZiting Xu0Yang Gao1Li Zhang2Yingshan Gao3Yushu Liao4Yu Liang5Zhen Yuan6Yingjia Li7Bingxia Zhao8Ge Wen9Department of Medical Imaging, Department of Ultrasound, Nanfang Hospital, Southern Medical UniversityDepartment of Medical Imaging, Department of Ultrasound, Nanfang Hospital, Southern Medical UniversityDepartment of Medical Imaging, Department of Ultrasound, Nanfang Hospital, Southern Medical UniversityDepartment of Medical Imaging, Department of Ultrasound, Nanfang Hospital, Southern Medical UniversityCancer Research Institute, School of Basic Medical Sciences, Southern Medical UniversityDepartment of Medical Imaging, Department of Ultrasound, Nanfang Hospital, Southern Medical UniversityFaculty of Health Sciences, University of MacauDepartment of Medical Imaging, Department of Ultrasound, Nanfang Hospital, Southern Medical UniversityCancer Research Institute, School of Basic Medical Sciences, Southern Medical UniversityDepartment of Medical Imaging, Department of Ultrasound, Nanfang Hospital, Southern Medical UniversityAbstract The immunosuppressive tumor microenvironment (ITME) and inherent radioresistance of tumor cells limit the effectiveness of radioimmunotherapy and exacerbate immune evasion. To address these challenges, PEGylated Azacitidine-loaded and Mn2+-doped calcium carbonate nanoparticles (A@MCP NPs) are synthesized as multifunctional nanoagent to enhance radioimmunotherapy outcomes. Upon acidic TME, the release of Ca2+ and Mn2+ from A@MCP NPs co-triggers intracellular reactive oxygen species (ROS) generation via Ca2+ overload and Fenton-like reactions, inducing cytochrome C release and caspase-3 activation. Concurrently, released Azacitidine inhibits DNA methylation, upregulating GSDME expression in irradiated tumor cells, which synergistically amplifies caspase-3/GSDME-induced pyroptosis. The resulting pyroptotic cell damage, coupled with radiotherapy (RT)-induced DNA, activates Mn2+-sensitized cGAS-STING pathways, amplifying immune responses. Collectively, A@MCP, as a nano radiosensitizer, together with RT, co-activates pyroptosis and cGAS-STING to further amplify anti-tumor immune response, overcome ITME-mediated resistance and offer significant potential for improved cancer radioimmunotherapy.https://doi.org/10.1186/s12951-025-03608-3RadiosensitizationPyroptosiscGAS-STING pathwayCa overloadRadioimmunotherapy
spellingShingle Ziting Xu
Yang Gao
Li Zhang
Yingshan Gao
Yushu Liao
Yu Liang
Zhen Yuan
Yingjia Li
Bingxia Zhao
Ge Wen
Multifunctional nanoagent for enhanced cancer radioimmunotherapy via pyroptosis and cGAS-STING activation
Journal of Nanobiotechnology
Radiosensitization
Pyroptosis
cGAS-STING pathway
Ca overload
Radioimmunotherapy
title Multifunctional nanoagent for enhanced cancer radioimmunotherapy via pyroptosis and cGAS-STING activation
title_full Multifunctional nanoagent for enhanced cancer radioimmunotherapy via pyroptosis and cGAS-STING activation
title_fullStr Multifunctional nanoagent for enhanced cancer radioimmunotherapy via pyroptosis and cGAS-STING activation
title_full_unstemmed Multifunctional nanoagent for enhanced cancer radioimmunotherapy via pyroptosis and cGAS-STING activation
title_short Multifunctional nanoagent for enhanced cancer radioimmunotherapy via pyroptosis and cGAS-STING activation
title_sort multifunctional nanoagent for enhanced cancer radioimmunotherapy via pyroptosis and cgas sting activation
topic Radiosensitization
Pyroptosis
cGAS-STING pathway
Ca overload
Radioimmunotherapy
url https://doi.org/10.1186/s12951-025-03608-3
work_keys_str_mv AT zitingxu multifunctionalnanoagentforenhancedcancerradioimmunotherapyviapyroptosisandcgasstingactivation
AT yanggao multifunctionalnanoagentforenhancedcancerradioimmunotherapyviapyroptosisandcgasstingactivation
AT lizhang multifunctionalnanoagentforenhancedcancerradioimmunotherapyviapyroptosisandcgasstingactivation
AT yingshangao multifunctionalnanoagentforenhancedcancerradioimmunotherapyviapyroptosisandcgasstingactivation
AT yushuliao multifunctionalnanoagentforenhancedcancerradioimmunotherapyviapyroptosisandcgasstingactivation
AT yuliang multifunctionalnanoagentforenhancedcancerradioimmunotherapyviapyroptosisandcgasstingactivation
AT zhenyuan multifunctionalnanoagentforenhancedcancerradioimmunotherapyviapyroptosisandcgasstingactivation
AT yingjiali multifunctionalnanoagentforenhancedcancerradioimmunotherapyviapyroptosisandcgasstingactivation
AT bingxiazhao multifunctionalnanoagentforenhancedcancerradioimmunotherapyviapyroptosisandcgasstingactivation
AT gewen multifunctionalnanoagentforenhancedcancerradioimmunotherapyviapyroptosisandcgasstingactivation